SEC Company Response from Wave Life Sciences, (WVE) — May 2, 2022
Wave Life Sciences, Inc.
Date: May 2, 2022 · CIK: 0001631574 · Accession: 0001193125-22-136918
AI Filing Summary & Sentiment
File numbers found in text: 333-263251
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Registration Statement on Form S-3 Filed March 3, 2022 File No. 333-263251 Acceleration Request
Dear Mr. Buchmiller:
With respect to the above-referenced Registration Statement on Form S-3 (the “Registration Statement”), and pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests, on behalf of Wave Life Sciences Ltd. (the “Company”), that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the Registration Statement to Wednesday, May 4, 2022, at 4:00 p.m. Eastern Time, or as soon as practicable thereafter.
The cooperation of the staff in meeting the timetable described above is very much appreciated.
Please call John T. Rudy or John P. Condon of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (617) 542-6000, with any comments or questions regarding the Registration Statement.
Very truly yours,
WAVE LIFE SCIENCES LTD.
Show Raw Text
CORRESP 1 filename1.htm CORRESP WAVE LIFE SCIENCES LTD. 7 Straits View #12-00, Marina One East Tower Singapore 018936 May 2, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Tim Buchmiller RE: Wave Life Sciences Ltd. Registration Statement on Form S-3 Filed March 3, 2022 File No. 333-263251 Acceleration Request Dear Mr. Buchmiller: With respect to the above-referenced Registration Statement on Form S-3 (the “Registration Statement”), and pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, the undersigned hereby respectfully requests, on behalf of Wave Life Sciences Ltd. (the “Company”), that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the Registration Statement to Wednesday, May 4, 2022, at 4:00 p.m. Eastern Time, or as soon as practicable thereafter. The cooperation of the staff in meeting the timetable described above is very much appreciated. Please call John T. Rudy or John P. Condon of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, at (617) 542-6000, with any comments or questions regarding the Registration Statement. Very truly yours, WAVE LIFE SCIENCES LTD. /s/ Kyle Moran Kyle Moran Chief Financial Officer cc: Linda Rockett, Esq., Senior Vice President, General Counsel, Wave Life Sciences Ltd. John T. Rudy, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. John P. Condon, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.